Skip to main content
OpenTrials
Completed

NCT Number: NCT03072862

Evaluation of the Benefits for Overall Health Following Cochlear Implant Treatment in the Elderly Population

The purpose of this study is to show that cochlear implant treatment improves the overall health related quality of life and general well-being in elderly individuals.

Completed

Looking for future studies?

Notify Me

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Groupe Hospitalier de La Pitié Salpétrière, Paris, France

Loading trial locations.

About this study

The study is designed as an observational prospective repeated measures study with each subject acting as his/her own control. Subjects are evaluated subjectively at pre- and post-operative intervals that coincide with their routine visits to the clinic. Outcomes from routine practice and application of cochlear implant intervention are recorded through observational measures using clinical standards scales used widely in geriatrics and audiology. The study is aimed at collection of data for patients who have already made the decision together with their implant centre clinician for an implant device from the company Cochlear. Patients are approached for study participation prior to surgery by the caring clinician on a consecutive and voluntary basis and on condition of signing the patient informed consent.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Unilateral CI candidates with bilateral post-lingual deafness with intention to treat
  • ≥ 60 years at first unilateral cochlear implant
  • Implant ear: meets all local criteria for cochlear implant treatment
  • Contralateral ear: average pure tone thresholds indicate a moderately-severe to profound hearing loss (4 freq. average: 0.5, 1, 2 and 3 or 4 kHz > 56 dBHL).
  • Willingness to participate in and to comply with all study procedures
  • Fluency in languages used to assess clinical performance
  • Appropriate expectations from routine cochlear implant treatment
  • Able to decide on study participation personally and independently sign their consent

Exclusion criteria

  • Significantly/severely dependent or fragile
  • Unable to provide consent personally
  • Unable to complete questionnaires for self-assessment independently
  • Unilateral hearing loss
  • Sequential and simultaneous bilateral cochlear implant recipients
  • Ossification or other cochlear anomalies preventing full electrode insertion
  • Retro cochlear or central origins of hearing impairment.
  • Significant comorbidities preventing study participation (e.g. blindness, immobility or in a wheel chair, severe aphasia)
  • Medical contraindications to surgery
  • Clinic Standard fail criteria for cochlear implant candidacy in regards to chronic depression, dementia, and cognitive disorders.
  • Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and prosthetic device.

Treatment and study plan

Commercial Nucleus Cochlear Implant Systems

Device

Commercially available Nucleus Cochlear Implant Systems, including Data Logging functionality

Primary outcomes

  1. Change in Health Related Quality of Life Following Cochlear Implant Treatment

    Time frame: pre-implant surgery, 12 months post-surgery

    Assessed via the Health Utilities Index Mark III (HUI 3) questionnaire. HUI-3 classification system consists of 8 attributes including vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain. HUI-3 values range from -0.36 to 1.00. A health utility value of 1.00 indicates perfect health while a score of 0.00 indicates death. The change in scores is presented. A positive value indicates an improved quality of life, a negative value indicates impaired quality of life.

  2. Change in Health Related Quality of Life Following Cochlear Implant Treatment

    Time frame: pre-implant surgery, 18 months post-surgery

    Assessed via the Health Utilities Index Mark III (HUI 3) questionnaire. HUI-3 classification system consists of 8 attributes including vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain. HUI-3 values range from -0.36 to 1.00. A health utility value of 1.00 indicates perfect health while a score of 0.00 indicates death. The change in scores will be presented. A positive value indicates an improved quality of life, a negative value indicates impaired quality of life.

Sponsors and collaborators

Lead sponsor

Cochlear

Industry

Registry information

Official study title

Cochlear Implant and Healthy Aging: A Multinational, Multicentre Observational Study

Important dates

Study start
2017
Primary completion
2022
Study completion
2022
First posted
Mar 7, 2017
Registry last updated
Jan 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.